ST. LOUIS, March 15, 2012 /PRNewswire/ -- Sigma-Aldrich
Corporation (Nasdaq: SIAL) recently completed a 57,000-square-foot
expansion of its Bangalore, India,
campus. The expansion, which includes an expanded distribution
center and new packaging facility, enhances the Company's
distribution capabilities in the Asia-Pacific region, increasing operational
excellence in one of the industry's key markets. The new
additions complement existing R&D, custom synthesis and
manufacturing infrastructure and expand a localized approach to
better support customers in India
as well as the Asia-Pacific
region.
(Logo:
http://photos.prnewswire.com/prnh/20050215/CGSIGMAALLOGO)
"Sigma-Aldrich has built a strong foundation, achieving
consistent double-digit sales growth driven by our first-to-move
advantage, our approach in providing excellent service, our
investments and our high standards for operation. A key focus in
the Asia-Pacific and Latin America regions has been to accelerate
localization to continue to drive further growth," said
Eric Green, Vice President and
Managing Director, International at Sigma-Aldrich.
This latest expansion enables Sigma-Aldrich to provide turnkey
services at the Bangalore site -
improving service levels for customers in the region. The new
addition features approximately 49,000 square feet of distribution
space and 8,000 square feet of packaging space. The existing
10-acre campus will continue to house the administrative offices;
sales; marketing and distribution functions; and manufacturing.
Sigma-Aldrich President and Chief
Executive Officer Rakesh Sachdev was
joined by approximately 100 invited guests from across the
pharmaceutical, biopharmaceutical and CRO industries, government
research institutes and academia to open the facility by "lighting
the lamp," an Indian tradition.
"India is a key location for
us, where we engage in the entire spectrum of activity including
manufacturing, R & D, packaging and distribution. The country
has huge potential and we plan to continue our focus in this
important market," said Sachdev. "We currently have small scale
manufacturing in India. Based on
customer input, we are evaluating further expansion programs that
could include larger scale manufacturing in the
future."
Sigma-Aldrich has an aggressive growth strategy for the
Asia-Pacific region, particularly
India and China. The Company's latest investment in the
Bangalore facility is consistent
with its strategy of expanding products and services, driving
operational excellence and focusing on the needs of its
customers. It has operated in Bangalore since 1991 and has been at its
current location since 2006.
Cautionary Statement: The foregoing release contains
forward-looking statements that can be identified by terminology
such as "will further enable," "will continue," "will be" or
similar expressions, or by expressed or implied discussions
regarding potential future outcomes from the facility derived
therefrom. You should not place undue reliance on these statements.
Such forward-looking statements reflect the current views of
management regarding future events, and involve known and unknown
risks, uncertainties and other factors that may cause actual
results to be materially different from any future results,
performance or achievements expressed or implied by such
statements. There can be no guarantee that this facility will
assist the Company to achieve any particular levels of revenue in
the future. In particular, management's expectations regarding the
facility could be affected by, among other things, unexpected
regulatory actions or delays or government regulation generally;
the Company's ability to obtain or maintain patent or other
proprietary intellectual property protection; competition in
general; government, industry and general public pricing pressures;
the impact that the foregoing factors could have on the values
attributed to the Company's assets and liabilities as recorded in
its consolidated balance sheet, and other risks and factors
referred to in Sigma-Aldrich's current Form 10-K on file with the
US Securities and Exchange Commission. Should one or more of these
risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated, believed, estimated or expected.
Sigma-Aldrich is providing the information in this press release as
of this date and does not undertake any obligation to update any
forward-looking statements contained in this press release as a
result of new information, future events or otherwise.
About Sigma-Aldrich: Sigma-Aldrich is a leading
Life Science and High Technology company whose biochemical, organic
chemical products, kits and services are used in scientific
research, including genomic and proteomic research, biotechnology,
pharmaceutical development, the diagnosis of disease and as key
components in pharmaceutical, diagnostics and high technology
manufacturing. Sigma-Aldrich customers include more than 1.3
million scientists and technologists in life science companies,
university and government institutions, hospitals and industry. The
Company operates in 40 countries and has nearly 9,000 employees
whose objective is to provide excellent service worldwide.
Sigma-Aldrich is committed to accelerating customer success through
innovation and leadership in Life Science and High
Technology. For more information about Sigma-Aldrich, please
visit its website at http://www.sigma-aldrich.com/.
Sigma-Aldrich and Sigma are trademarks of Sigma-Aldrich Co. LLC
registered in the US and other countries.
SOURCE Sigma-Aldrich Corporation